NORTHWEST BIOTHERAPEUTICS INC Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Northwest Biotherapeutics Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Northwest Biotherapeutics Inc Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 1.29B shares, a 12.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.29B +141M +12.3% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 1.23B +115M +10.3% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 1.2B +112M +10.4% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 1.18B +107M +10% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 1.15B +1.15B Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.12B +80.7M +7.8% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 1.08B +113M +11.7% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 1.07B +120M +12.7% Dec 31, 2022 10-K 2024-03-05
Q3 2022 1.05K* -892M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 1.03B +177M +20.7% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 970M +140M +16.9% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 948M +119M +14.3% Dec 31, 2021 10-K 2023-02-28
Q3 2021 892M +112M +14.4% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 857M +135M +18.7% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 830M +168M +25.3% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 830M +215M +35% Dec 31, 2020 10-K 2022-03-01
Q3 2020 780M +197M +33.8% Sep 30, 2020 10-Q 2021-01-15
Q2 2020 722M +160M +28.4% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 662M +125M +23.3% Mar 31, 2020 10-Q 2020-06-24
Q4 2019 614M +91.1M +17.4% Dec 31, 2019 10-K 2021-03-31
Q3 2019 583M +72.7M +14.3% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 563M +118M +26.5% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 537M +122M +29.5% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 523M +194M +59.1% Dec 31, 2018 10-K 2020-03-16
Q3 2018 510M +200M +64.7% Sep 30, 2018 10-Q 2018-11-16
Q2 2018 445M +207M +87.3% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 415M +229M +124% Mar 31, 2018 10-Q 2018-05-16
Q4 2017 329M +172M +109% Dec 31, 2017 10-K 2019-04-02
Q3 2017 310M +189M +156% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 237M +131M +124% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 186M +83.8M +82.3% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 157M +61.1M +63.8% Dec 31, 2016 10-K 2018-04-17
Q3 2016 121M +42.6M +54.5% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 106M +28.4M +36.6% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 102M +31.4M +44.7% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 95.9M +26.9M +39% Dec 31, 2015 10-K 2017-04-17
Q3 2015 78.2M +16M +25.6% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 77.7M +18.9M +32.2% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 70.3M +15.5M +28.3% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 69M +23.3M +51% Dec 31, 2014 10-K 2016-03-16
Q3 2014 62.2M +25.6M +69.8% Sep 30, 2014 10-Q 2014-11-19
Q2 2014 58.8M +28M +91.3% Jun 30, 2014 10-Q 2014-08-15
Q1 2014 54.8M +27.7M +102% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 45.7M +21M +85.1% Dec 31, 2013 10-K 2015-03-17
Q3 2013 36.6M +24.8M +210% Sep 30, 2013 10-Q 2013-11-15
Q2 2013 30.7M -135M -81.4% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 27.1M -132M -83% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 24.7M +15.3M +164% Dec 31, 2012 10-K 2014-04-01
Q3 2012 11.8M -85.3M -87.8% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 165M +71.9M +77% Jun 30, 2012 10-Q/A 2012-09-12
Q1 2012 159M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 9.33M -63.8M -87.2% Dec 31, 2011 10-K 2013-04-08
Q3 2011 97.1M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 93.4M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 73.1M Dec 31, 2010 10-K 2012-04-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.